Xcout Intel
92Bio
92Bio is a clinical-stage biotechnology company headquartered in Hayward, California, that develops next-generation T-cell engaging antibodies for therapeutic treatments.
Subscribe to see 92Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
92Bio at a glance
92Bio is a biotechnology company headquartered in United States. Xcout tracks 12 named people at 92Bio, including Ben Buelow (Chief Executive Officer).
92Bio leadership
- Ben BuelowChief Executive Officer
- Suhasini IyerChief Development Officer
- Andrew BoudreauVP, Informatics
- Antara BanerjeeVP, Discovery Biology
- Ashwin PatelVP, Clinical Operations
- Patrick KoenigVP, Biologics
6 more named people on record for 92Bio, with roles, board committees and tenure — see the full roster →
92Bio competitors
A few of 92Bio's closest competitors — see the full list of competitors and alternatives →
Aptevo Therapeutics Inc. is a public, clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for immuno-oncology.
Laigo Bio is a biotechnology company that develops targeted protein degradation therapeutics using its proprietary SureTAC platform. The company utilizes bispecific antibodies to direct cell surface targets toward lysosomal degradation, primarily serving the oncology and immunology sectors.
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
VelosBio Inc. is a clinical-stage biopharmaceutical company based in California, United States, focused on developing novel antibody-drug conjugates to transform cancer treatment for patients.
9Bio Therapeutics is a biotechnology company that combines biology, structural engineering, and artificial intelligence to pioneer next-generation biologics for advanced cancers. The company is headquartered in Quebec, Canada.
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Get 92Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on 92Bio in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access